First human tests for experimental herpes drug show promise
NCT ID NCT06385327
Summary
This early-stage study tested the safety and how the body processes a new experimental drug called ABI-5366. It involved 115 healthy volunteers and people with recurrent genital herpes. The main goals were to check for side effects, measure drug levels in the blood, and see if the drug reduced the herpes virus in participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GENITAL HERPES SIMPLEX TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Canopy Beaches Clinical Research
Sydney, New South Wales, 2100, Australia
-
Canopy Clinical Sutherland
Miranda, New South Wales, 2228, Australia
-
Canopy Clinical Wollongong
Wollongong, New South Wales, 2500, Australia
-
East Sydney Doctors
Darlinghurst, New South Wales, 2010, Australia
-
Momentum Clinical Research
Sydney, New South Wales, 2010, Australia
-
Momentum Kapiti
Waikanae, 5036, New Zealand
-
Momentum Palmerston North
Palmerston North, 4414, New Zealand
-
Momentum Sunshine
Melbourne, Victoria, 3021, Australia
-
New Zealand Clinical Research
Auckland, 1010, New Zealand
-
New Zealand Clinical Research Christchurch
Christchurch, 8011, New Zealand
-
Pacific Clinical Research Network - Hamilton
Hamilton, 3200, New Zealand
-
Pacific Clinical Research Network - Rotorua
Rotorua, 3010, New Zealand
-
Pacific Clinical Research Network - Tasman
Nelson, 7011, New Zealand
-
Pacific Clinical Research Network - Wellington
Upper Hutt, 5018, New Zealand
-
Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
Conditions
Explore the condition pages connected to this study.